ALL-PARTY PARLIAMENTARY GROUP FOR ETHNICITY TRANSPLANTATION AND TRANSFUSION

​

The recently formed All-Party Parliamentary Group for Ethnicity Transplantation and Transfusion announced the launch of Parliamentary Inquiry into the access to donors for those from diverse ethnic backgrounds.

Kymriah approved for acute lymphoblastic leukaemia

​

Novartis has announced that the European Commission (EC) has approved Kymriah® for the treatment of paediatric and young adult patients up to 25 years of age with B-cell acute lymphoblastic leukaemia (ALL).

Jazz Pharma’s leukaemia drug wins EU approval for AML

​

The European Commission has approved Jazz Pharmaceuticals' Vyxeos for the treatment of adults with newly diagnosed, therapy-related acute myeloid leukaemia or AML with myelodysplasia-related changes. 

Leukaemia scientist Dr Cristina Lo Celso given Royal Microscopical Society award

 

Dr Lo Celso is awarded the RMS Medal for Life Sciences for ‘outstanding scientific achievements applying microscopy in the field of cell biology’.

Wolves goalkeeper Carl Ikeme retires after year-long battle with leukaemia

 

Wolves goalkeeper Carl Ikeme, who was diagnosed with acute leukaemia in July 2017, has announced his retirement from football at the age of 32. The Nigeria international has been with the Molineux club for his whole career, making more than 200 appearances.

Biopharma’s acute myeloid leukaemia treatment gains orphan drug designation

​

Clinical-stage biopharmaceutical company, ASLAN Pharmaceuticals, has been granted orphan drug designation (ODD) for its treatment for acute myeloid leukaemia (AML) — ASLAN003 — by the US Food and Drug Administration (FDA).

Making chemotherapy kinder for childhood leukaemia

​

In this guest blog post, Dr Rosanna Jackson discusses what scientists are doing to make treatment kinder for children with acute lymphoblastic leukaemia (ALL).

Drug to treat childhood leukaemia to be made available on the NHS 

 

A cutting-edge personalised treatment for a form of childhood leukaemia is to be made available on the NHS in the first deal of its kind in Europe.

We can all help to fight leukaemia

 

Bone Marrow Stem Cell Donation and Leukaemia Awareness Month is commemorated annually from 15 August to 15 October. The fight against leukaemia and other blood diseases is all about you; your family, friends, peers and the community. You can do something to make a difference to patients needing a blood stem cell transplant

Blood test could predict leukaemia early

Researchers from Wellcome Sanger Institute and European Bioinformatics Institute (EMBL-EBI) have revealed that a blood test for changes in the DNA code can help predict a patient’s risk of developing acute myeloid leukaemia (AML) years before a positive diagnosis.​

Highgate School student, 16, diagnosed with Leukaemia in April secures straight A*s in his GCSEs

​

A 16-year-old Highgate School student who was diagnosed with Leukaemia in April has bagged straight A*s in his GCSE results.

New campaign puts spotlight on leukaemia

​

KEIGHLEY people are being urged to learn the symptoms of leukaemia. The plea has been issued by Leukaemia Care to coincide with Blood Cancer Awareness Month.

AZ’s new leukaemia drug approved in the US

 

The FDA has approved a new cancer drug from AstraZeneca, the first medicine to treat a rare and life-threatening form of leukaemia to hit the market for 20 years. 

Microsoft supports 3 South African Organisations With $1M 

 

Recipients of the grants are Youth Empowerment Services (YES), Peace Parks Foundation and the Sunflower Fund. The fund will create employment opportunities for youth, combat wildlife crime and support conservation work as well as advance healthcare solutions for those with Leukaemia and other life-threatening blood diseases.

BMX rider who broke his ankle shocked as blood test reveals he has leukaemia

​

When Matt Dalley fell off his BMX bike and broke his ankle, he had no idea that the accident would actually save his life. A GP advised him to have a blood test following the incident because Matt, who was aged 19 at the time, had little pinprick bruises on his foot where he'd fallen - and the results came back that he was suffering from leukaemia.